Arnold Foundation Will Retain Drug Pricing Focus As Health Care Agenda Grows

In an interview with the Pink Sheet, Laura and John Arnold Foundation VP Health Care Mark Miller discusses the foundation’s ongoing drug pricing priorities.

Drug costs_1B_546120055_1200.jpg

More from Pricing Debate

More from Market Access